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Colorectal cancer (CRC) is the third most common cancer type in both genders and arises 
from intestinal-epithelial cells (IECs), a cellular monolayer separating the gut lumen from the 
body. While only a minority of new diagnosed patients carries genetic predispositions, the 
major risk factors for CRC are age, inflammatory bowel diseases, and obesity.  
In this study, IEC-specific deficiencies of the insulin receptor (IR) and insulin-like growth 
factor receptor 1 (IGF1R) have been analyzed, allowing for the investigation whether IEC-
specific insulin resistance affects colitis-associated cancer (CAC) development and IEC 
integrity. Upon chemical CAC induction, IR/IGF1RIEC-KO mice exhibited accelerated tumor 
burden as a consequence of impaired gut barrier restoration. The compromised epithelial 
integrity in insulin resistant colons was caused by a decreased expression of the cell junction 
molecule Desmocollin 3 (Dsc3) that was directly controlled via insulin-regulated FoxO1 
transcription factors. Consistently, IEC-specific expression of an insulin insensitive 
FoxO1ADA construct and IEC-specific Dsc3 deficiency recapitulated the increased CAC 
development as a consequence of gut barrier defects like observed in IR/IGF1RIEC-KO mice. 
As part of the Desmosomes, DSC3 interconnects the IEC monolayer and conveys strength 
against mechanical forces. Thus, it facilitates the strict separation between gut lumen and 
underlying tissues, avoiding an inflammatory immune response. These findings demonstrate 
that the development of insulin resistance impacts on CAC development via impaired 
transcriptional control of Dsc3, resulting in compromised desmosome formation and impaired 
gut barrier restoration. 
